|
... into a leading discoverer and developer of RNA-based drugs. The corporate overview will include an update on AVI's Duchenne muscular dystrophy program (DMD), its biodefense projects (which include significant data from the Company's ongoing Ebola ...
|
|
A medical research team at Carolinas Medical Center in Charlotte headed by Qi Long Lu, M.D., Ph.D., has made a discovery that holds promise to restore muscle function in patients afflicted by Duchenne muscular ...
|
|
... therapeutic platform. The presentation will include specific updates on the Company's clinical programs in Duchenne Muscular Dystrophy (DMD), cardiovascular restenosis and AVI's biodefense collaboration with USAMRIID targeting Ebola, Marburg and ...
|